Kemira & IFF are expanding their strategic cooperation. The next step: first full-scale commercial biomanufacture of tailored biomaterials that provide novel high-performing alternatives to fossil-based products.
This venture enables the conversion of up to 44,000 metric tons/a of EU-produced beet sugar to bioproducts using IFF’s patented Designed Enzymatic Biomaterial™ (DEB™) platform technology integrated at the IFF biorefinery in Kotka, Finland.
The DEB™ technology leverages biotechnology to design polysaccharides through the enzymatic polymerization of simple plant sugars with high purity, conversion, consistency and selectivity., advancing product performance across key applications while allowing manufacturers to replace traditional fossil-based synthetic polymers with a more sustainable alternative.
IFF and Kemira have been collaborating in an exclusive partnership to design nature-identical renewable products which bring advantaged performance to both companies core markets”
– CHRISTIAN LENGES IFF Venture Leader & Alpha Bio Board Member
Kemira continues to receive increasing positive feedback from customers supporting the need for DEB™ based performance advantaged tailored biopolymers. We are excited to continue building the momentum for adoption of these novel materials in strategic markets such as paper and board based packaging, and water treatment with this full-scale manufacturing facility.”
– SAMPO LAHTINEN Executive Vice President, Research & Innovation, Kemira Oyj